The EU Pharmacovigilance Risk Assessment Committee (PRAC)

Each month, safety surveillance of medicines is discussed in the EU by the Pharmacovigilance Risk Assessment Committee (PRAC).

PRAC belongs under the London-based European Medicines Agency (EMA) and is made up of representatives from every EU Member State.

The main topics discussed and conclusions drawn at the PRAC meetings are posted on the EMA website after every meeting.

Link to PRAC: Agendas, minutes and highlights